+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Antibiotics Market Research Report by Action Mechanism, Drug Class, Spectrum, Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5264378
  • Report
  • April 2022
  • Region: Global
  • 210 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022
The Global Antibiotics Market size was estimated at USD 35,072.90 million in 2020, USD 37,250.93 million in 2021, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 6.32% to reach USD 50,662.67 million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Antibiotics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Action Mechanism, the market was studied across Cell Wall Synthesis Inhibitors, DNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Protein Synthesis Inhibitors, and RNA Synthesis Inhibitors.
  • Based on Drug Class, the market was studied across Aminoglycosides, Carbapenem, Cephalosporin, Fluoroquinolone, Macrolides, Penicillin, and Sulfonamides.
  • Based on Spectrum, the market was studied across Broad-spectrum Antibiotics and Narrow-spectrum Antibiotics.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Antibiotics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Antibiotics Market, including Abbott Laboratories, Akron Incorporated, Amneal Pharmaceuticals LLC, Astellas Pharma, Inc., Bausch Health Companies, Inc., Bayer AG, Bristol-Myers Squibb Company, Cadila Healthcare Ltd., Eli Lilly and Company, F. Hoffmann-La Roche AG, Johnson & Johnson, KYORIN Holdings, Inc., LG Chem Ltd., Lupin Limited, Melinta Therapeutics, Inc., Merck & Co., Inc., MerLion Pharmaceuticals GmbH, Mylan N.V., Novartis International AG, Pfizer Inc., Sanofi S.A., Shionogi & Co., Ltd., Sun Pharmaceutical Industries Limited, and Teva Pharmaceutical Industries Ltd..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Antibiotics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Antibiotics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Antibiotics Market?
4. What is the competitive strategic window for opportunities in the Global Antibiotics Market?
5. What are the technology trends and regulatory frameworks in the Global Antibiotics Market?
6. What is the market share of the leading vendors in the Global Antibiotics Market?
7. What modes and strategic moves are considered suitable for entering the Global Antibiotics Market?
Frequently Asked Questions about the Global Antibiotics Market

What is the estimated value of the Global Antibiotics Market?

The Global Antibiotics Market was estimated to be valued at $35072.9 Million in 2020.

What is the growth rate of the Global Antibiotics Market?

The growth rate of the Global Antibiotics Market is 6.3%, with an estimated value of $50662.7 Million by 2026.

What is the forecasted size of the Global Antibiotics Market?

The Global Antibiotics Market is estimated to be worth $50662.7 Million by 2026.

Who are the key companies in the Global Antibiotics Market?

Key companies in the Global Antibiotics Market include Abbott Laboratories, Akron Incorporated, Amneal Pharmaceuticals LLC, Astellas Pharma, Inc., Bausch Health Companies, Inc., Bayer AG, Bristol, Myers Squibb Company and Eli Lilly and Company.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Prevalence of Patients Suffering from Infectious Diseases
5.1.1.2. Development of Novel Strategies for New Antibiotics and a Large Number of Clinical Trials
5.1.1.3. Extended Consumption in Low and Middle-Income Countries
5.1.2. Restraints
5.1.2.1. Misuse of Antibiotics
5.1.3. Opportunities
5.1.3.1. Advanced Prospect Molecules and Novel Combination Therapies to Treat Antibiotic-Resistant Microbial Infections
5.1.3.2. Growing in R&D and Investments for New Drugs
5.1.4. Challenges
5.1.4.1. Side Effects Caused by the Usage of Antibiotic Drugs
5.2. Cumulative Impact of COVID-19
6. Antibiotics Market, by Action Mechanism
6.1. Introduction
6.2. Cell Wall Synthesis Inhibitors
6.3. DNA Synthesis Inhibitors
6.4. Mycolic Acid Inhibitors
6.5. Protein Synthesis Inhibitors
6.6. RNA Synthesis Inhibitors
7. Antibiotics Market, by Drug Class
7.1. Introduction
7.2. Aminoglycosides
7.3. Carbapenem
7.4. Cephalosporin
7.5. Fluoroquinolone
7.6. Macrolides
7.7. Penicillin
7.8. Sulfonamides
8. Antibiotics Market, by Spectrum
8.1. Introduction
8.2. Broad-spectrum Antibiotics
8.3. Narrow-spectrum Antibiotics
9. Americas Antibiotics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Antibiotics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Antibiotics Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abbott Laboratories
13.2. Akron Incorporated
13.3. Amneal Pharmaceuticals LLC
13.4. Astellas Pharma, Inc.
13.5. Bausch Health Companies, Inc.
13.6. Bayer AG
13.7. Bristol-Myers Squibb Company
13.8. Cadila Healthcare Ltd.
13.9. Eli Lilly and Company
13.10. F. Hoffmann-La Roche AG
13.11. Johnson & Johnson
13.12. KYORIN Holdings, Inc.
13.13. LG Chem Ltd.
13.14. Lupin Limited
13.15. Melinta Therapeutics, Inc.
13.16. Merck & Co., Inc.
13.17. MerLion Pharmaceuticals GmbH
13.18. Mylan N.V.
13.19. Novartis International AG
13.20. Pfizer Inc.
13.21. Sanofi S.A.
13.22. Shionogi & Co., Ltd.
13.23. Sun Pharmaceutical Industries Limited
13.24. Teva Pharmaceutical Industries Ltd.
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL ANTIBIOTICS MARKET: DYNAMICS
FIGURE 2. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2020 VS 2026 (%)
FIGURE 3. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2020 VS 2026 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2026
FIGURE 5. GLOBAL ANTIBIOTICS MARKET SIZE, BY CELL WALL SYNTHESIS INHIBITORS, 2018-2026 (USD MILLION)
FIGURE 6. GLOBAL ANTIBIOTICS MARKET SIZE, BY CELL WALL SYNTHESIS INHIBITORS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 7. GLOBAL ANTIBIOTICS MARKET SIZE, BY DNA SYNTHESIS INHIBITORS, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL ANTIBIOTICS MARKET SIZE, BY DNA SYNTHESIS INHIBITORS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 9. GLOBAL ANTIBIOTICS MARKET SIZE, BY MYCOLIC ACID INHIBITORS, 2018-2026 (USD MILLION)
FIGURE 10. GLOBAL ANTIBIOTICS MARKET SIZE, BY MYCOLIC ACID INHIBITORS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 11. GLOBAL ANTIBIOTICS MARKET SIZE, BY PROTEIN SYNTHESIS INHIBITORS, 2018-2026 (USD MILLION)
FIGURE 12. GLOBAL ANTIBIOTICS MARKET SIZE, BY PROTEIN SYNTHESIS INHIBITORS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 13. GLOBAL ANTIBIOTICS MARKET SIZE, BY RNA SYNTHESIS INHIBITORS, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL ANTIBIOTICS MARKET SIZE, BY RNA SYNTHESIS INHIBITORS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2020 VS 2026 (%)
FIGURE 16. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2020 VS 2026 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2026
FIGURE 18. GLOBAL ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL ANTIBIOTICS MARKET SIZE, BY CARBAPENEM, 2018-2026 (USD MILLION)
FIGURE 21. GLOBAL ANTIBIOTICS MARKET SIZE, BY CARBAPENEM, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 22. GLOBAL ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN, 2018-2026 (USD MILLION)
FIGURE 23. GLOBAL ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 24. GLOBAL ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONE, 2018-2026 (USD MILLION)
FIGURE 25. GLOBAL ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 26. GLOBAL ANTIBIOTICS MARKET SIZE, BY MACROLIDES, 2018-2026 (USD MILLION)
FIGURE 27. GLOBAL ANTIBIOTICS MARKET SIZE, BY MACROLIDES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 28. GLOBAL ANTIBIOTICS MARKET SIZE, BY PENICILLIN, 2018-2026 (USD MILLION)
FIGURE 29. GLOBAL ANTIBIOTICS MARKET SIZE, BY PENICILLIN, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 30. GLOBAL ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, 2018-2026 (USD MILLION)
FIGURE 31. GLOBAL ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 32. GLOBAL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2020 VS 2026 (%)
FIGURE 33. GLOBAL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2020 VS 2026 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2026
FIGURE 35. GLOBAL ANTIBIOTICS MARKET SIZE, BY BROAD-SPECTRUM ANTIBIOTICS, 2018-2026 (USD MILLION)
FIGURE 36. GLOBAL ANTIBIOTICS MARKET SIZE, BY BROAD-SPECTRUM ANTIBIOTICS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 37. GLOBAL ANTIBIOTICS MARKET SIZE, BY NARROW-SPECTRUM ANTIBIOTICS, 2018-2026 (USD MILLION)
FIGURE 38. GLOBAL ANTIBIOTICS MARKET SIZE, BY NARROW-SPECTRUM ANTIBIOTICS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 39. AMERICAS ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 40. ARGENTINA ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 41. BRAZIL ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 42. CANADA ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 43. MEXICO ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 44. UNITED STATES ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. AUSTRALIA ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. CHINA ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. INDIA ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. INDONESIA ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. JAPAN ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. MALAYSIA ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. PHILIPPINES ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. SINGAPORE ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. SOUTH KOREA ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. TAIWAN ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. THAILAND ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. FRANCE ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. GERMANY ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. ITALY ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. NETHERLANDS ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. QATAR ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. RUSSIA ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 64. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 65. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 66. SPAIN ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 67. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 68. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 69. GLOBAL ANTIBIOTICS MARKET: FPNV POSITIONING MATRIX
FIGURE 70. GLOBAL ANTIBIOTICS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 71. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANTIBIOTICS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL ANTIBIOTICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL ANTIBIOTICS MARKET SIZE, BY CELL WALL SYNTHESIS INHIBITORS, BY REGION, 2018-2026 (USD MILLION)
TABLE 5. AMERICAS ANTIBIOTICS MARKET SIZE, BY CELL WALL SYNTHESIS INHIBITORS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES ANTIBIOTICS MARKET SIZE, BY CELL WALL SYNTHESIS INHIBITORS, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY CELL WALL SYNTHESIS INHIBITORS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY CELL WALL SYNTHESIS INHIBITORS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL ANTIBIOTICS MARKET SIZE, BY DNA SYNTHESIS INHIBITORS, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. AMERICAS ANTIBIOTICS MARKET SIZE, BY DNA SYNTHESIS INHIBITORS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES ANTIBIOTICS MARKET SIZE, BY DNA SYNTHESIS INHIBITORS, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY DNA SYNTHESIS INHIBITORS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY DNA SYNTHESIS INHIBITORS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL ANTIBIOTICS MARKET SIZE, BY MYCOLIC ACID INHIBITORS, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. AMERICAS ANTIBIOTICS MARKET SIZE, BY MYCOLIC ACID INHIBITORS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES ANTIBIOTICS MARKET SIZE, BY MYCOLIC ACID INHIBITORS, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY MYCOLIC ACID INHIBITORS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY MYCOLIC ACID INHIBITORS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL ANTIBIOTICS MARKET SIZE, BY PROTEIN SYNTHESIS INHIBITORS, BY REGION, 2018-2026 (USD MILLION)
TABLE 20. AMERICAS ANTIBIOTICS MARKET SIZE, BY PROTEIN SYNTHESIS INHIBITORS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 21. UNITED STATES ANTIBIOTICS MARKET SIZE, BY PROTEIN SYNTHESIS INHIBITORS, BY STATE, 2018-2026 (USD MILLION)
TABLE 22. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY PROTEIN SYNTHESIS INHIBITORS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY PROTEIN SYNTHESIS INHIBITORS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 24. GLOBAL ANTIBIOTICS MARKET SIZE, BY RNA SYNTHESIS INHIBITORS, BY REGION, 2018-2026 (USD MILLION)
TABLE 25. AMERICAS ANTIBIOTICS MARKET SIZE, BY RNA SYNTHESIS INHIBITORS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 26. UNITED STATES ANTIBIOTICS MARKET SIZE, BY RNA SYNTHESIS INHIBITORS, BY STATE, 2018-2026 (USD MILLION)
TABLE 27. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY RNA SYNTHESIS INHIBITORS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY RNA SYNTHESIS INHIBITORS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 29. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD MILLION)
TABLE 30. GLOBAL ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2026 (USD MILLION)
TABLE 31. AMERICAS ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 32. UNITED STATES ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, BY STATE, 2018-2026 (USD MILLION)
TABLE 33. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 35. GLOBAL ANTIBIOTICS MARKET SIZE, BY CARBAPENEM, BY REGION, 2018-2026 (USD MILLION)
TABLE 36. AMERICAS ANTIBIOTICS MARKET SIZE, BY CARBAPENEM, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 37. UNITED STATES ANTIBIOTICS MARKET SIZE, BY CARBAPENEM, BY STATE, 2018-2026 (USD MILLION)
TABLE 38. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY CARBAPENEM, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY CARBAPENEM, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 40. GLOBAL ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN, BY REGION, 2018-2026 (USD MILLION)
TABLE 41. AMERICAS ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 42. UNITED STATES ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN, BY STATE, 2018-2026 (USD MILLION)
TABLE 43. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 45. GLOBAL ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONE, BY REGION, 2018-2026 (USD MILLION)
TABLE 46. AMERICAS ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 47. UNITED STATES ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONE, BY STATE, 2018-2026 (USD MILLION)
TABLE 48. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 50. GLOBAL ANTIBIOTICS MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2026 (USD MILLION)
TABLE 51. AMERICAS ANTIBIOTICS MARKET SIZE, BY MACROLIDES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 52. UNITED STATES ANTIBIOTICS MARKET SIZE, BY MACROLIDES, BY STATE, 2018-2026 (USD MILLION)
TABLE 53. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY MACROLIDES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY MACROLIDES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 55. GLOBAL ANTIBIOTICS MARKET SIZE, BY PENICILLIN, BY REGION, 2018-2026 (USD MILLION)
TABLE 56. AMERICAS ANTIBIOTICS MARKET SIZE, BY PENICILLIN, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 57. UNITED STATES ANTIBIOTICS MARKET SIZE, BY PENICILLIN, BY STATE, 2018-2026 (USD MILLION)
TABLE 58. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY PENICILLIN, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY PENICILLIN, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 60. GLOBAL ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, BY REGION, 2018-2026 (USD MILLION)
TABLE 61. AMERICAS ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 62. UNITED STATES ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, BY STATE, 2018-2026 (USD MILLION)
TABLE 63. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 65. GLOBAL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2026 (USD MILLION)
TABLE 66. GLOBAL ANTIBIOTICS MARKET SIZE, BY BROAD-SPECTRUM ANTIBIOTICS, BY REGION, 2018-2026 (USD MILLION)
TABLE 67. AMERICAS ANTIBIOTICS MARKET SIZE, BY BROAD-SPECTRUM ANTIBIOTICS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 68. UNITED STATES ANTIBIOTICS MARKET SIZE, BY BROAD-SPECTRUM ANTIBIOTICS, BY STATE, 2018-2026 (USD MILLION)
TABLE 69. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY BROAD-SPECTRUM ANTIBIOTICS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY BROAD-SPECTRUM ANTIBIOTICS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 71. GLOBAL ANTIBIOTICS MARKET SIZE, BY NARROW-SPECTRUM ANTIBIOTICS, BY REGION, 2018-2026 (USD MILLION)
TABLE 72. AMERICAS ANTIBIOTICS MARKET SIZE, BY NARROW-SPECTRUM ANTIBIOTICS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 73. UNITED STATES ANTIBIOTICS MARKET SIZE, BY NARROW-SPECTRUM ANTIBIOTICS, BY STATE, 2018-2026 (USD MILLION)
TABLE 74. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY NARROW-SPECTRUM ANTIBIOTICS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY NARROW-SPECTRUM ANTIBIOTICS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 76. AMERICAS ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 77. ARGENTINA ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 78. BRAZIL ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 79. CANADA ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 80. MEXICO ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 81. UNITED STATES ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 82. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 83. AUSTRALIA ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 84. CHINA ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 85. INDIA ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 86. INDONESIA ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 87. JAPAN ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 88. MALAYSIA ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 89. PHILIPPINES ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 90. SINGAPORE ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 91. SOUTH KOREA ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 92. TAIWAN ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 93. THAILAND ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 95. FRANCE ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 96. GERMANY ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 97. ITALY ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 98. NETHERLANDS ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 99. QATAR ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 100. RUSSIA ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 101. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 102. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 103. SPAIN ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 104. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 105. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 106. GLOBAL ANTIBIOTICS MARKET: SCORES
TABLE 107. GLOBAL ANTIBIOTICS MARKET: BUSINESS STRATEGY
TABLE 108. GLOBAL ANTIBIOTICS MARKET: PRODUCT SATISFACTION
TABLE 109. GLOBAL ANTIBIOTICS MARKET: RANKING
TABLE 110. GLOBAL ANTIBIOTICS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 111. GLOBAL ANTIBIOTICS MARKET: MERGER & ACQUISITION
TABLE 112. GLOBAL ANTIBIOTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 113. GLOBAL ANTIBIOTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 114. GLOBAL ANTIBIOTICS MARKET: INVESTMENT & FUNDING
TABLE 115. GLOBAL ANTIBIOTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 116. GLOBAL ANTIBIOTICS MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Akron Incorporated
  • Amneal Pharmaceuticals LLC
  • Astellas Pharma, Inc.
  • Bausch Health Companies, Inc.
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Cadila Healthcare Ltd.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • KYORIN Holdings, Inc.
  • LG Chem Ltd.
  • Lupin Limited
  • Melinta Therapeutics, Inc.
  • Merck & Co., Inc.
  • MerLion Pharmaceuticals GmbH
  • Mylan N.V.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Shionogi & Co., Ltd.
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...